Dyrness Albert D. - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 30, 2023, Dyrness Albert D.'s relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Director, and currently has 28,962 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SONN insiders.
Data Source: SEC.
Dyrness Albert D. - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 31, 2023 | P -- (Common Stock) | 23255 | 0.47 | 28962 |